Trials / Sponsors / Xilio Development, Inc.
Xilio Development, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | XTX301 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-05-11 |
| Completed | XTX202 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-01-18 |
| Recruiting | Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2021-09-13 |